Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Allogeneic Donors”

15 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 15 results

Not applicableStudy completedNCT01901458
What this trial is testing

Two Different Collection Sets for Peripheral Blood Progenitor Cell Apheresis With Spectra Optia®

Who this might be right for
Healthy Allogeneic DonorsGranulocyte Colony-stimulating Factor (G-CSF) Mobilized
Heinrich-Heine University, Duesseldorf 50
Not applicableStudy completedNCT02716571
What this trial is testing

Recruiting Blood Donor With Allogeneic Natural Killer Cell

Who this might be right for
Healthy Volunteers
Seoul National University Hospital 90
Testing effectiveness (Phase 2)Study completedNCT01954914
What this trial is testing

Plerixafor as a Salvage Regimen to Mobilize Allogeneic Stem Cells in Healthy Volunteers

Who this might be right for
Blood Stem Cell Harvest Failure
Technische Universität Dresden 39
Early research (Phase 1)Looking for participantsNCT07115745
What this trial is testing

Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases

Who this might be right for
Refractory Autoimmune Diseases
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 125
Testing effectiveness (Phase 2)Study completedNCT02424968
What this trial is testing

CD8+ Memory T-Cells as Consolidative Therapy After Donor Non-myeloablative Hematopoietic Cell Transplant in Treating Patients With Leukemia or Lymphoma

Who this might be right for
Acute Myeloid LeukemiaB-Cell Non-Hodgkin LymphomaChronic Lymphocytic Leukemia+4 more
Robert Lowsky 18
Post-approval studies (Phase 4)Looking for participantsNCT01553214
What this trial is testing

Improving White Blood Cell Collection From Healthy Donors

Who this might be right for
Allogeneic Granulocyte Donation
National Institutes of Health Clinical Center (CC) 1,000
Early research (Phase 1)Enrolling By InvitationNCT06508138
What this trial is testing

Clinical Trial Assessing the Safety and Immunologic Correlates of Heterologous Prime-Boost With pNGVL4a-Sig/E7(Detox)/HSP70 and TA-HPV in Healthy Donors Followed by Peripheral Blood Collection

Who this might be right for
HPV 16 InfectionHPV-Related CarcinomaRecurrence+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 24
Early research (Phase 1)Study completedNCT01287104
What this trial is testing

A Phase I Study of NK Cell Infusion Following Allogeneic Peripheral Blood Stem Cell Transplantation From Related or Matched Unrelated Donors in Pediatric Patients With Solid Tumors and Leukemias

Who this might be right for
LeukemiaLymphoma
National Cancer Institute (NCI) 34
Large-scale testing (Phase 3)Study completedNCT00005782
What this trial is testing

Mobilization and Handling of Stem Cells for Transplant From Healthy Volunteers With Sickle Cell Trait

Who this might be right for
Sickle Cell Trait
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 12
Not applicableStudy completedNCT01463475
What this trial is testing

University of Wisconsin hMSC Cell Bank: Bone Marrow Donor Protocol

Who this might be right for
Graft Versus Host Disease (GVHD)Acute Myocardial Infarction (AMI)
University of Wisconsin, Madison 3
Large-scale testing (Phase 3)Looking for participantsNCT00785525
What this trial is testing

Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors

Who this might be right for
Healthy
Center for International Blood and Marrow Transplant Research 60,000
Not applicableLooking for participantsNCT00001529
What this trial is testing

Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives

Who this might be right for
Graft-Versus-Host DiseaseGraft-versus-leukemiaDonor Apheresis
National Heart, Lung, and Blood Institute (NHLBI) 500
Not applicableStudy completedNCT00511550
What this trial is testing

Filgrastim-Mobilized Peripheral Blood Stem Cells for Allogeneic Transplantation With Unrelated Donors

Who this might be right for
Healthy
University of California, San Francisco 15
Not applicableStudy completedNCT01766934
What this trial is testing

Non-interventional, Long-term Safety Data Collection of Zarzio® / Filgrastim HEXAL® in Stem Cell Donors

Who this might be right for
Hematopoietic Stem Cell Mobilization
Sandoz 245
Testing effectiveness (Phase 2)Ended earlyNCT04762875
What this trial is testing

MGTA-145 + Plerixafor in the Mobilization of HSCs for Allogeneic Transplant in Hematologic Malignancies

Who this might be right for
Related Donors Donating PBSC to a Family MemberHealthy DonorsAcute Myelogenous Leukemia+2 more
Ensoma 7